LB Pharmaceuticals grants 200,000-share option awards to new CMO and CFO
LBRX•LB Pharmaceuticals granted new executives Susan G. Kozauer and Joseph Miller options covering 200,000 shares each, priced at $37.22 per share, on Oct. 9, 2026.
LBRX•LBRX•
